Trial Outcomes & Findings for High Intensity Interval Training in Endometrial Cancer (NCT NCT04025229)

NCT ID: NCT04025229

Last Updated: 2025-10-15

Results Overview

Change in Ki-67 proliferation values within the HIIT intervention group between the initial biopsy and the surgical biopsy. The percentage of tumor cells that are positive for Ki-67, indicating they are in the active phases of the cell cycle (not resting). Low Ki-67 (\<10-15%): Slower-growing tumor. Intermediate (15-30%): Moderately proliferative. High (\>30%): Fast-growing, potentially more aggressive.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

30 participants

Primary outcome timeframe

3 years

Results posted on

2025-10-15

Participant Flow

Participants enrolled were enrolled at a single North Carolina site between 09/23/2019 and 09/08/2022.

Thirty participants consented and began the study.

Participant milestones

Participant milestones
Measure
Control Arm
No HIIT exercise prior to surgery
HIIT Exercise
Participants will perform HIIT exercises as instructed by the study team in the weeks prior to standard of care surgery. HIIT exercise: High-intensity interval training (4 to 6 sessions) prior to surgery.
Overall Study
STARTED
10
20
Overall Study
COMPLETED
9
16
Overall Study
NOT COMPLETED
1
4

Reasons for withdrawal

Reasons for withdrawal
Measure
Control Arm
No HIIT exercise prior to surgery
HIIT Exercise
Participants will perform HIIT exercises as instructed by the study team in the weeks prior to standard of care surgery. HIIT exercise: High-intensity interval training (4 to 6 sessions) prior to surgery.
Overall Study
Adverse Event
1
0
Overall Study
Withdrawal by Subject
0
2
Overall Study
Death
0
1
Overall Study
Physician Decision
0
1

Baseline Characteristics

High Intensity Interval Training in Endometrial Cancer

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Control Arm
n=9 Participants
No HIIT exercise prior to surgery.
HIIT Exercise
n=16 Participants
Participants will perform HIIT exercises as instructed by the study team in the weeks prior to standard of care surgery. HIIT exercise: High-intensity interval training (4 to 6 sessions) prior to surgery
Total
n=25 Participants
Total of all reporting groups
Age, Continuous
58.9 years
STANDARD_DEVIATION 5.3 • n=5 Participants
54.9 years
STANDARD_DEVIATION 8.2 • n=7 Participants
56.4 years
STANDARD_DEVIATION 7.4 • n=5 Participants
Sex: Female, Male
Female
9 Participants
n=5 Participants
16 Participants
n=7 Participants
25 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
9 Participants
n=5 Participants
15 Participants
n=7 Participants
24 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
4 Participants
n=7 Participants
5 Participants
n=5 Participants
Race (NIH/OMB)
White
8 Participants
n=5 Participants
12 Participants
n=7 Participants
20 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
9 participants
n=5 Participants
16 participants
n=7 Participants
25 participants
n=5 Participants

PRIMARY outcome

Timeframe: 3 years

Population: Participants who started the study and provided a sample were included.

Change in Ki-67 proliferation values within the HIIT intervention group between the initial biopsy and the surgical biopsy. The percentage of tumor cells that are positive for Ki-67, indicating they are in the active phases of the cell cycle (not resting). Low Ki-67 (\<10-15%): Slower-growing tumor. Intermediate (15-30%): Moderately proliferative. High (\>30%): Fast-growing, potentially more aggressive.

Outcome measures

Outcome measures
Measure
Control Arm- Baseline
n=8 Participants
The sample provided by participants who will perform HIIT exercises as instructed by the study team in the weeks prior to standard of care surgery at baseline.
Control Arm -At Surgery
n=8 Participants
The sample provided by participants who will perform HIIT exercises as instructed by the study team in the weeks prior to standard of care surgery at surgery.
HIIT- Baseline
n=16 Participants
The sample provided by participants who will perform HIIT exercises as instructed by the study team at baseline.
HIIT -At Surgery
n=16 Participants
The sample provided by participants who will perform HIIT exercises as instructed by the study team during surgery.
Change in Proliferative Markers in Endometrium Before and After HIIT Exercises
21.7 Percentage of cells expressing Ki67
Standard Deviation 12.2
15.1 Percentage of cells expressing Ki67
Standard Deviation 14.4
21.7 Percentage of cells expressing Ki67
Standard Deviation 12.2
20.2 Percentage of cells expressing Ki67
Standard Deviation 15.7

Adverse Events

HIIT Exercise

Serious events: 0 serious events
Other events: 0 other events
Deaths: 1 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Luz Andrea Cuaboy

UNC Lineberger Comprehensive Cancer Center

Phone: 1-919-843-1177

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place